Roche Breast Cancer Drug Delays Progression by Over Four Months

Roche

Roche Holding Ag’s experimental drug giredestrant reduced the risk of breast cancer worsening by almost two thirds in some patients with an advanced form of the disease.

Tag-uri: Roche

Roche Breast Cancer Drug Delays Progression by Over Four Months https://www.bloomberg.com - 18.10.2025 05:00
Roche Breast Cancer Drug Delays Progression by Over Four Months https://www.bloomberg.com - 18.10.2025 05:00

din zilele anterioare

Roche Breast Cancer Drug Delays Progression by Over Four Months https://www.bloomberg.com - 18.10.2025 05:00
Roche Breast Cancer Drug Delays Progression by Over Four Months https://www.bloomberg.com - 18.10.2025 05:00